IQVIA Holdings Inc

IQV

$261.61

+76.1% (1 year change)

Market Cap

$50.3 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$146.03 - $265.34

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

82.79x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $50.3 Billion
Enterprise Value $60.7 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return +76.1%
52-Week High $265.34
52-Week Low $146.03
Beta 1.02
Outstanding Shares 192 Million
Avg 30 Day Volume 566 Thousand

Valuation

P/E Ratio 82.79
PEG 52.22
Earnings per Share $3.10
Price to Sales Ratio 4.22
Price to Book Ratio 8.72
Revenue to Enterprise Value 5.06
EBIT to Enterprise Value 65.17
Total Debt to Enterprise Value 0.2
Debt to Equity 2.13

Profitability

Revenue $12 Billion
Gross Profit $4.05 Billion
EBIT $932 Million
Net Income $409 Million
Profit Margin 3.4%
Quarterly Earnings Growth (YoY) +158.5%
Return on Equity 7.1%
Return on Assets 1.71%
Return on Invested Capital 4.87%

News

IQVIA Holdings  Consensus Indicates Potential 8.0% Upside

IQVIA Holdings Consensus Indicates Potential 8.0% Upside

IQVIA Holdings found using ticker (IQV) have now 19 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is...

DirectorsTalk DirectorsTalk, 9 days ago
Why Are NRx Pharma Shares Moving Higher On Tuesday Premarket?

Why Are NRx Pharma Shares Moving Higher On Tuesday Premarket?

Iqvia Holdings Inc (NYSE: IQV ) has collaborated with NRx Pharmaceuticals Inc (NASDAQ: NRXP ) to provide pharmacovigilance services and medical information in preparation for potential Full story ...

Benzinga Benzinga, 11 days ago
IQVIA CFO, Ron Bruehlman, to Speak at the Baird 2021 Global Healthcare Conference on September 14, 2021

IQVIA CFO, Ron Bruehlman, to Speak at the Baird 2021 Global Healthcare Conference on September 14, 2021

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will participate in ...

Business Wire Business Wire, 23 days ago